Rheumatologists at the ACR’s State-of-the-Art Clinical Symposium in Chicago discuss medication alternatives to bisphosphonates that reduce bone resorption, build bone density and may provide new treatment options
Search results for: romosozumab
Rheumatology Drug Updates, Trials, Safety Data
Information on acetaminophen restrictions; trials for clazakizumab, epratuzumab, romosozumab; and drug safety updates rheumatologists need to know